0001493152-20-022153.txt : 20201120
0001493152-20-022153.hdr.sgml : 20201120
20201120180012
ACCESSION NUMBER: 0001493152-20-022153
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201120
FILED AS OF DATE: 20201120
DATE AS OF CHANGE: 20201120
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wider Todd
CENTRAL INDEX KEY: 0001642715
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15771
FILM NUMBER: 201333694
MAIL ADDRESS:
STREET 1: 4848 LEMMON AVENUE, SUITE 517
CITY: DALLAS
STATE: TX
ZIP: 75219
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ABEONA THERAPEUTICS INC.
CENTRAL INDEX KEY: 0000318306
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 830221517
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1330 AVENUE OF THE AMERICAS, 33RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: 646-813-4701
MAIL ADDRESS:
STREET 1: 1330 AVENUE OF THE AMERICAS, 33RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
FORMER COMPANY:
FORMER CONFORMED NAME: PLASMATECH BIOPHARMACEUTICALS INC
DATE OF NAME CHANGE: 20140922
FORMER COMPANY:
FORMER CONFORMED NAME: ACCESS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19960209
FORMER COMPANY:
FORMER CONFORMED NAME: CHEMEX PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19920703
4
1
ownership.xml
X0306
4
2020-11-20
0
0000318306
ABEONA THERAPEUTICS INC.
ABEO
0001642715
Wider Todd
1330 AVENUE OF THE AMERICAS, 33RD FLOOR
NEW YORK
NY
10019
1
0
0
0
Stock Option (right to buy)
1.28
2020-11-20
4
A
0
21518
A
2030-05-20
Common Stock
21518
21518
D
Stock Option (right to buy)
3.20
2020-11-20
4
D
0
21518
D
2030-05-20
Common Stock
21518
0
D
Stock Option (right to buy)
1.28
2020-11-20
4
A
0
19827
A
2029-05-21
Common Stock
19827
19827
D
Stock Option (right to buy)
7.42
2020-11-20
4
D
0
19827
D
2029-05-21
Common Stock
19827
0
D
Stock Option (right to buy)
1.28
2020-11-20
4
A
0
50000
A
2028-03-29
Common Stock
50000
50000
D
Stock Option (right to buy)
13.65
2020-11-20
4
D
0
50000
D
2028-03-29
Common Stock
50000
0
D
Stock Option (right to buy)
1.28
2020-11-20
4
A
0
30000
A
2027-12-14
Common Stock
30000
30000
D
Stock Option (right to buy)
16.00
2020-11-20
4
D
0
30000
D
2027-12-14
Common Stock
30000
0
D
Stock Option (right to buy)
1.28
2020-11-20
4
A
0
50000
A
2026-12-13
Common Stock
50000
50000
D
Stock Option (right to buy)
4.45
2020-11-20
4
D
0
50000
D
2026-12-13
Common Stock
50000
0
D
Stock Option (right to buy)
1.28
2020-11-20
4
A
0
50000
A
2026-02-11
Common Stock
50000
50000
D
Stock Option (right to buy)
2.31
2020-11-20
4
D
0
50000
D
2026-02-11
Common Stock
50000
0
D
Stock Option (right to buy)
1.28
2020-11-20
4
A
0
100000
A
2025-05-11
Common Stock
100000
100000
D
Stock Option (right to buy)
7.34
2020-11-20
4
D
0
100000
D
2025-05-11
Common Stock
100000
0
D
The options vest 100% on November 20, 2020.
The options granted on May 20, 2020, May 21, 2019, March 29, 2018, December 14, 2017, December 13, 2016, February 11, 2016 and May 11, 2015 have each been modified to reflect a lower exercise price.
The options vested 100% on November 21, 2019.
The options vested 100% on September 29, 2018.
The options vested 100% on June 14, 2018.
The options vested 100% on June 13, 2017.
The options vested 100% on August 11, 2016.
The options vested 100% on November 11, 2015.
/s/ Brendan M. O'Malley, as Attorney-in-fact
2020-11-20